Ribosomal protein L36a pseudogene 45 (RPL36AP45)

Ribosomal protein L36a pseudogene 45 (RPL36AP45) is classified as a *pseudogene*—a gene sequence similar to the protein-coding gene ribosomal protein L36a (RPL36A), but which does not encode a functional protein due to mutations such as insertions, deletions, or premature stop codons[1][2]. RPL36AP45 is one of several processed pseudogenes derived from RPL36A, dispersed in the genome as nonfunctional copies[1][2][4][7]. Ribosomal protein pseudogenes generally do not participate directly in protein synthesis or known cellular pathways. While some pseudogenes in general may play regulatory or non-coding RNA roles, current evidence does not ascribe any such function to RPL36AP45. It is not a recognized therapeutic target, biomarker, or drug-interactive gene. If you are seeking information on the functional ribosomal protein, you should refer to **ribosomal protein L36a (RPL36A)**, which is a component of the 60S ribosomal subunit involved in protein synthesis[4][7]. Key Note: This entry is not considered a *therapeutic target* (enzyme, receptor, transporter, etc.) and instead is a non-coding genomic feature. There is no evidence of a direct role in disease, drug interaction, or biological function for patient selection or monitoring. Its only established identity is as a pseudogene related to the RPL36A gene[1][2][7].

Other names

RPL36A_20_1453RPL36AP45